๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Phase 2

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma NCT06342167Phase 210 sites๐Ÿ“ Beijing๐Ÿ“ Fujian๐Ÿ“ Handan Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites๐Ÿ“ Bergen๐Ÿ“ Oslo๐Ÿ“ Tromsรธ Oslo University Hospital ยท Tests: preoperative, Quality of life, Functional outcome SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer๏ผˆSPARKLE๏ผ‰ NCT06767007Phase 21 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Stereotactic Body Radiation Therapy (SBRT), PD1, Chemotherapy Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer NCT06525428Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: standard systemic therapy combined with high/low-dose radiotherapy plus toripalimab A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Orlando Iovance Biotherapeutics, Inc. ยท Tests: Lifileucel Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer NCT06451211Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Tislelizumab, Oxaliplatin, S-1, Capecitabine Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor NCT05933395Phase 21 site๐Ÿ“ Lebanon Dartmouth-Hitchcock Medical Center ยท Tests: Fulvestrant, Neratinib, Alpelisib, Everolimus, Abemaciclib A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) NCT07355075Phase 2, Phase 31 site๐Ÿ“ Irving Turn Therapeutics ยท Tests: GX-03, Vehicle Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 NCT07070999Phase 1, Phase 21 site๐Ÿ“ Porto Alegre Gemma Biotherapeutics ยท Tests: GB221 Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Toripalimab, Carboplatin, Paclitaxel The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation NCT06843551Phase 21 site๐Ÿ“ Miami Benjamin Spieler ยท Tests: Stereotactic Body Radiation Therapy, Botensilimab, Balstilimab To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies NCT07795034Phase 21 site๐Ÿ“ Xiamen Neuboron Bio-SciTech Co., Ltd. ยท Tests: Boron Neutron Capture Therapy A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder NCT07475806Phase 266 sites๐Ÿ“ Little Rock๐Ÿ“ Stanford๐Ÿ“ Chicago Astellas Pharma Global Development, Inc. ยท Tests: Enfortumab Vedotin, Pembrolizumab A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers NCT07539415Phase 11 site๐Ÿ“ Seoul Daewoong Pharmaceutical Co. LTD. ยท Tests: DWRX5003, DWC202502, DWC202503, DWRX5003P Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer NCT05998135Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: Atovaquone, Biopsy, Computed Tomography, Paracentesis PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER NCT07178808Phase 21 site๐Ÿ“ Gilbert Banner Health ยท Tests: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site๐Ÿ“ Hangzhou Zeng Jian ยท Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC) NCT07055399Phase 21 site๐Ÿ“ Fuzhou Fujian Cancer Hospital ยท Tests: neoadjuvant chemo-immunotherapy: Iparomlimab and tuvonralimab plus cisplatin,nab-paclitaxel for 1 cycle and Iparomlimabโ€ฆ FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Chengdu Guangdong Association of Clinical Trials ยท Tests: Sintilimab Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas NCT04620187Phase 213 sites๐Ÿ“ Atlanta๐Ÿ“ Chicago๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma NCT07096778Phase 231 sites๐Ÿ“ Phoenix๐Ÿ“ San Francisco๐Ÿ“ Jacksonville CellCentric Ltd. ยท Tests: Inobrodib, Pomalidomide, Dexamethasone A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) NCT05519085Phase 3266 sites๐Ÿ“ Los Alamitos๐Ÿ“ San Diego๐Ÿ“ West Hollywood Celgene ยท Tests: mezigdomide, Pomalidomide, Bortezomib, Dexamethasone TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: TILs๏ผˆTumor Infiltrating Lymphocytes๏ผ‰ A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) NCT07137598Phase 265 sites๐Ÿ“ Avondale๐Ÿ“ Peoria๐Ÿ“ La Jolla Hoffmann-La Roche ยท Tests: Afimkibart, Placebo Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors NCT06835387Phase 27 sites๐Ÿ“ Tampa๐Ÿ“ Chicago๐Ÿ“ Fort Wayne Tiago Biachi de Castria ยท Tests: Nanoliposomal irinotecan, Oxaliplatin, 5 fluorouracil, Leucovorin A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) NCT07373964Phase 21 site๐Ÿ“ Shenyang China Medical University, China ยท Tests: Chidamide Tablets๏ผ› PD-L1 Inhibitor (as per chosen drug's prescribing information)๏ผ›Carboplatin๏ผ› Etoposide A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010) NCT07785609Phase 24 sites๐Ÿ“ San Antonio๐Ÿ“ Hong Kong๐Ÿ“ Bellinzona Merck Sharp & Dohme LLC ยท Tests: MK-2010, Sacituzumab tirumotecan, Histamine H1 Receptor Antagonist, Histamine H2 Receptor Antagonist, Acetaminophen (orโ€ฆ Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003) NCT06561399n/a4 sites๐Ÿ“ Fuzhou๐Ÿ“ Fuzhou๐Ÿ“ Fuzhou Fujian Provincial Hospital ยท Tests: TACE, Lenvatinib combination with Sintilimab sequential radiotherapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy